Majority of US Physicians Decline COVID Shots, According to Survey

By Association of American Physicians and Surgeons
Global Research, July 27, 2021
Association of American Physicians and Surgeons 16 June 2021
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). 

Visit and follow us on Instagram at @crg_globalresearch.

First published by Global Research on June 21, 2021

***

Of the 700 physicians responding to an internet survey by the Association of American Physicians and Surgeons (AAPS), nearly 60 percent said they were not “fully vaccinated” against COVID.

This contrasts with the claim by the American Medical Association that 96 percent of practicing physicians are fully vaccinated. This was based on 300 respondents.

Neither survey represents a random sample of all American physicians, but the AAPS survey shows that physician support for the mass injection campaign is far from unanimous.

“It is wrong to call a person who declines a shot an ‘anti-vaxxer,’” states AAPS executive director Jane Orient, M.D. “Virtually no physicians are ‘anti-antibiotics’ or ‘anti-surgery,’ whereas all are opposed to treatments that they think are unnecessary, more likely to harm than to benefit an individual patient, or inadequately tested.”

The AAPS survey also showed that 54 percent of physician respondents were aware of patients suffering a “significant adverse reaction.” Of the unvaccinated physicians, 80 percent said “I believe risk of shots exceeds risk of disease,” and 30% said “I already had COVID.”

Other reasons for declining the shot included unknown long-term effects, use of aborted fetal tissue, “it’s experimental,” availability of effective early treatment, and reports of deaths and blood clots.

Of 560 practicing physicians, 56 percent said they offered early treatment  for COVID.

Nonphysicians were also invited to participate in the survey. Of some 5,300 total participants, 2,548 volunteered comments about associated adverse effects of which they were aware. These included death, amputation, paralysis, stillbirth, menstrual irregularities, blindness, seizures, and heart issues.

“Causality is not proven. However, many of these episodes might have resulted in a huge product liability or malpractice award if they had occurred after a new drug,” stated Dr. Orient. “Purveyors of these COVID products are protected against lawsuits.”

The Association of American Physicians and Surgeons has represented physicians in all specialties since 1943. Its motto is omnia pro aegroto, everything for the patient.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Mercola

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]